Prices delayed by at least 15 minutes | Print
Mgc Pharmaceuticals Limited (MXC)
ORD NPV (DI)Open
21p
Previous close
21p
Trade high
24p
Volume
19,997
Year high
600.00p
Year low
13.10p
Dividend yield
-
Market capitalisation
£9.87 mn
P/E ratio
-
ISIN
AU000000MXC6
This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Share price
Company profile
MGC Pharmaceuticals Ltd is a biopharma company with a Nature to Medicine strategy at the forefront of the emerging phytocannabinoid and plant-derived medicine markets. The company's mission is to build an innovative, global bio-pharma company providing standardized, affordable plant-derived medicines of the highest regulatory compliance for targeted global markets.
News
Recent trades
Date | Time | Price | Quantity | Value (£) |
---|---|---|---|---|
28/03/2024 | 02:29:42 | 22.5 | 666 | 149.85 |
28/03/2024 | 02:24:07 | 21.1 | 3 | 0.63 |
28/03/2024 | 02:10:45 | 22.5 | 93 | 20.93 |
28/03/2024 | 01:37:34 | 21.1 | 35 | 7.39 |
28/03/2024 | 01:22:09 | 21.2 | 10 | 2.12 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.